Prevalence of injecting drug use and associated risk behavior among regular ecstasy users in Australia

Drug and Alcohol Dependence

Volumn 83, Issue 3, 2006, Pages 210-217

  White, Bethany ^a   Day, Carolyn ^b   Degenhardt, Louisa ^a   Kinner, Stuart ^c   Fry, Craig ^d   Bruno, Raimondo ^e   Johnston, Jennifer ^d  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d TURNING POINT ALCOHOL AND DRUG CENTRE   (Australia)

^e UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Ecstasy; Hepatitis C; Injecting drug use; Injecting risk behaviour; Methamphetamine

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE;

ARTICLE; AUSTRALIA; DEMOGRAPHY; DRUG ABUSE; DRUG MARKETING; EDUCATION; HETEROSEXUALITY; HIGH RISK BEHAVIOR; HIGH SCHOOL; HUMAN; INTERVIEW; LIFESPAN; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PRISON; RISK FACTOR; SENESCENCE; UNEMPLOYMENT;

ADULT; AMPHETAMINE-RELATED DISORDERS; AUSTRALIA; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HALLUCINOGENS; HEPATITIS B; HEPATITIS B VACCINES; HEPATITIS C; HEROIN DEPENDENCE; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; MASS SCREENING; METHAMPHETAMINE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEEDLE SHARING; POPULATION SURVEILLANCE; QUESTIONNAIRES; RISK-TAKING; SEXUAL BEHAVIOR; SOCIOECONOMIC FACTORS; STREET DRUGS; SUBSTANCE ABUSE, INTRAVENOUS; URBAN POPULATION;

EID: 33745214215     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2005.11.014     Document Type: Article

References (46)

1. Abraham, M., Kaal, H., Cohen, P., 2002. Licit and illicit drug use in the Netherlands 2001. Amsterdam, CEDRO/Mets en Schilt.
2. Alati R., Kinner S., and Najman J.M. Gender differences in the relationships among alcohol, tobacco and mental health in Emergency Department presentations. Alcohol Alcoholism 39 (2004)
3. Australian Institute of Health and Welfare, 2005. 2004 National Drug Strategy Household Survey: First Results. Australian Institute of Health and Welfare, Canberra.
4. Bailey S.L., Huo D., Garfein R.S., and Ouellet L.J. The use of needle exchange by young injection drug users. J. AIDS 34 (2003) 67-70
5. Beck F., Iegleye S., and Peretti-Watel P. Survey EROPP 2002 (2003), OFDT, Paris
6. Buxton M.B., Vlahov D., Strathdee S.A., Des Jarlais D.C., Morse E.V., Ouellet L., Kerndt P., and Garfein R.S. Association between injection practices and duration of injection among recently initiated injection drug users. Drug Alcohol Depend. 75 (2004) 177-183
7. Biernacki P., and Waldorf D. Snowball sampling: problems, techniques and chain referral sampling. Soc. Meth. Res. 10 (1981) 141-163
8. Breen C., Degenhardt L., White B., Bruno R., Chanteloup F., Fischer J., Moon C., Proudfoot P., Richards J., Ward J., and Weekley J. Australian Party Drug Trends 2003. Findings from the Party Drugs Initiative (PDI) (2003), National Drug and Alcohol Research Centre, Monograph No. 52, NDARC, Sydney
9. Carlson R.G., Wang J.S., and Siegal H.A. Drug use practices among MDMA/ecstasy users in Ohio: a latent class analysis. Drug Alcohol Depend. 79 (2005) 167-179
10. Cole J., and Sumnall H. Altered states: the clinical effects of ecstasy. Pharmacol. Ther. 98 (2003) 35-58
11. Cole J., Sumnall H., and Wagstaff G. What is a does of ecstasy?. J. Psychopharmacol. (Oxford) 16 (2002) 185-186
12. Condon, J., Smith, N., 2003. Prevalence of drug use: key findings from the 2002/2003 British Crime Survey. London, Home Office.
13. Crofts N., Jolley D., Kaldor J., van Beek I., and Wodak A. Epidemiology of hepatitis C virus infection among injecting drug users in Australia. J. Epidemiol. Commun. H 51 (1997) 692-697
14. Day C., White B., Ross J., and Dolan K. Poor knowledge and low coverage of hepatitis B vaccination among injecting drug users in Sydney (Letter). Aust. NZ J. Publ. Heal. 27 (2003) 558
15. Degenhardt L., Barker B., and Topp L. Patterns of ecstasy use in Australia: findings from a national household survey. Addiction 99 (2004) 187-195
16. Drucker E., Lurie P., Wodak A., and Alcabes P. Measuring harm reduction: the effects of needle and syringe exchange programs and methadone maintenance on the ecology of HIV. AIDS 12 (1998) S217-S230
17. Garfein R.S., Doherty M.C., Monterroso E.R., Thomas D.L., Nelson K.E., and Vlahov D. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. J. AIDS 18 (1998) S11-S19
18. Gerra G., Zaimovic A., Ferri M., Zambelli U., Timpano M., Neri E., Marzocchi G.F., Delsignore R., and Brambilla F. Long-lasting effects of (-/+)3,4-methylenedioxymethamphetamine (ecstasy) on serotonin system function in humans. Biol. Psychiatr. 47 (2000) 127-136
19. Hagan H., Thiede H., Weiss N., Hopkins S., Duchin J., and Alexander E. Sharing of drug preparation equipment as a risk factor for hepatitis C. Am. J. Publ. Health 91 (2001) 42-46
20. Hurley S.F., Jolley D.J., and Kaldor J.M. Effectiveness of needle-exchange programmes for prevention of HIV infection. Lancet 349 (1997) 1797-1800
21. Johnston L.D., O'Malley P.M., Bachman J.G., and Schulenberg J.E. Monitoring the Future National Survey Results on Drug Use, 1975-2003. Vol. II: College Students and Adults Ages 19-45, NIH Publication No. 04-5508 (2004), National Institute on Drug Abuse, Bethesda, MD
22. Kerlinger F.N. Foundations of Behavioral Research (1986), CBS Publishing Limited, Japan
23. Klitzman R.L., Greenberg J.D., Pollack L.M., and Dolezal C. MDMA ('ecstasy') use, and its association with high risk behaviours, mental health and other factors among gay/bisexual men in New York City. Drug Alcohol Depend. 66 (2002) 115-125
24. Kuo I., Sherman S.G., Thomas D.L., and Strathdee S.A. Hepatitis B virus infection and vaccination among young injection and non-injection drug users: missed opportunities to prevent infection. Drug Alcohol Depend. 73 (2004) 69-78
25. Kwiatkowski C.F., Fortuin Corsi K., and Booth R.E. The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users. Addiction 97 (2002) 1289-1294
26. Lenton S., Kerry K., Loxley W., Tan-Quigley A., and Greig R. Citizens who inject drugs: the 'Fitpack' study. Int. J. Drug Policy 11 (2000) 285-297
27. MacDonald M., Law M., Kaldor J., Hales J., and Dore G. Effectiveness of needle and syringe programmes for preventing HIV transmission. Int. J. Drug Policy 14 (2003) 353-357
28. McGregor L.S., Marks P.J., Hayward A., Bell Y., and Slack R.C.B. Factors influencing hepatitis B vaccine uptake in injecting drug users. J. Publ. Health Med. 25 (2003) 165-170
29. Miller C.L., Johnston C., Spittal P.M., Li K., Laliberte N., Montaner J.S., and Schechter M.T. Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users. Hepatology 36 (2002) 737-742
30. Moore D. Social controls, harm minimisation and interactive outreach: the public health implications of an ethnography of drug use. Aust. J. Publ. Health 17 (1993) 58-67
31. Quinn C., Breen C., and White B. Party Drug Trends Bulletin (2004), National Drug and Alcohol Research Centre, Sydney
32. Solowij N., Hall W., and Lee N. Recreational MDMA use in Sydney: a profile of 'ecstasy' users and their experiences with the drug. Brit. J. Addict. 87 (1992) 1161-1172
33. SPSS Inc. SPSS for Windows. 11.0 ed. (2001), SPSS Inc., Chicago
34. Stafford J., Degenhardt L., Agaliotis M., Chanteloup F., Fischer J., Matthews A., Newman J., Proudfoot P., Stoove M., and Weekley J. Australian Trends in Ecstasy and Related Drug Markets 2004: Findings from the Party Drugs Initiative (2005), National Drug and Alcohol Research Centre, Monograph No. 57, NDARC, Sydney
35. Stafford, J., Degenhardt, L., Black, E., Bruno, R., Buckingham, K., Fetherston, J., Jenkinson, R., Kinner, S., Moon, C., Weekley, J., 2005b. Australian Drug Trends 2004 Findings from the Illicit Drug Reporting System (IDRS). Monograph No. 55, NDARC, Sydney.
36. Substance Abuse and Mental Health Services Administration, 2005. Results from the 2004 National Survey on Drug Use and Health: National Findings. Office of Applied Studies, NSDUH Series H-28, DHHS Publication No. SMA 05-4062. DHHS, Rockville, MD.
37. Thein H., Denoe M., van Beek I., Dore G., and MacDonald M. Injecting behaviour of injecting drug users at needle and syringe programmes and pharmacies in Australia. Int. J. Drug Policy 14 (2003) 430-452
38. Topp L., Barker B., and Degenhardt L. The external validity of results derived from ecstasy users recruited using purposive sampling strategies. Drug Alcohol Depend. 73 (2004) 33-40
39. Topp L., Breen C., Kaye S., and Darke S. Adapting the illicit drug reporting system (IDRS) methodology to examine the feasibility of monitoring trends in party drug markets. Drug Alcohol Depend. 73 (2004) 189-197
40. Topp L., Hando J., Dillon P., Roche A., and Solowij N. Ecstasy use in Australia: patterns of use and associated harm. Drug Alcohol Depend. 55 (1999)
41. van Beek I., Dwyer R., Dore G., Luo K., and Kaldor J. Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study. Br. Med. J. 317 (1998) 433-437
42. Villano S.A., Vlahov D., Nelson K.E., Lyles C.M., Cohn S., and Thomas D.L. Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland. J. Clin. Microbiol. 35 (1997) 3274-3277
43. Waldo C.R., McFarland W., Katz M.H., MacKellar D., and Valleroy L.A. Very young gay and bisexual men are at risk for HIV infection: the San Francisco Bay Area Young Men's Survey II. J. AIDS 24 (2000) 168-174
44. Warner-Smith M., Darke S., Lynskey M., and Hall W. Heroin overdose: causes and consequences. Addiction 96 (2001) 1113-1125
45. Weinhardt L.S., Carey M.P., Johnson B.T., and Bickham N.L. Effects of HIV counseling and testing on sexual risk behavior: a meta-analytic review of published research 1985-1997. Am. J. Publ. Health 89 (1999) 1397-1405
46. Williamson S., Gossop M., Powis B., Griffiths P., Fountain J., and Strang J. Adverse effects of stimulant drugs in a community sample of drug users. Drug Alcohol Depend. 44 (1997) 87-94